WorldUpstart U.S. Market Gateway Accelerator Companies, Philadelphia, PA | Swiss Company MYNERVA

October 28 - 30, 2024 | Philadelphia

WorldUpstart proudly announces the launch of its Fall 2024 U.S. Market Gateway Accelerator, featuring nine innovative Life Science and MedTech companies poised for significant growth.

This year's participants were selected from a competitive pool of over 100 applicants, including startups and established companies specializing in Drug Development, Medical Devices, and Digital Health from around the globe. The chosen companies, representing France, Israel, Italy, Poland, South Korea, and Switzerland, are set to embark on a journey to expand into the dynamic U.S. market. Through WorldUpstart's intensive accelerator program, these companies will gain valuable insights, mentorship, and access to strategic networks, providing them with the tools and support needed for a successful market entry.

Meet the Swiss Company Selected this Fall:

MYNERVA developed innovative AI-driven non-invasive neurostimulation devices designed to alleviate chronic pain and restore the sense of touch in patients with diabetic neuropathy. 

For more details, please visit: WorldUpstart

About WorldUpstart 

WorldUpstart is committed to supporting international companies in the Life Science, MedTech, and Digital Health sectors as they prepare to enter the U.S. market. The U.S. Market Gateway Accelerator is designed to help companies overcome market entry challenges, develop strategic expansion roadmaps, and connect with key players, partners, and investors. Over the past three years, the program has graduated 65 companies from 18 countries, with 27 now established in the U.S. and eight achieving FDA approval for their products and services.